Indications for Ewing Battery Testing
The Ewing battery should be performed to diagnose and stage cardiovascular autonomic neuropathy (CAN) in diabetic patients, particularly when screening for orthostatic symptoms, evaluating unexplained tachycardia, or assessing patients before exercise programs. 1
Primary Indications
Diagnostic Situations
- Suspected CAN diagnosis and staging - The Ewing battery (cardiovascular autonomic reflex tests/CARTs) represents the gold standard for clinical autonomic testing and is required for definitive CAN diagnosis 1
- Orthostatic symptoms - Any diabetic patient with dizziness, lightheadedness, or syncope on standing requires testing 1
- Unexplained tachycardia in diabetic patients warrants CAN testing 1
- QTc prolongation - While insufficient alone for CAN diagnosis, this finding should prompt further autonomic testing 1
- Reverse dipping pattern on ambulatory blood pressure monitoring - Referral for CAN testing is advisable 1
Screening Recommendations
- Yearly orthostatic hypotension testing is recommended regardless of symptoms, particularly in:
- Before initiating exercise programs - CAN testing identifies patients with poor exercise performance potential and prevents adverse outcomes when introducing training programs 1
Clinical Context for Testing
The Ewing battery has proven utility beyond diabetes. Research demonstrates its value in:
- Differentiating parkinsonian syndromes - The battery shows 91% sensitivity and 94% specificity in distinguishing MSA-P from Parkinson's disease at early stages 2
- Cerebellar ataxias - Detecting early blood pressure dysregulation that may be missed at bedside, particularly in sporadic cases that may convert to MSA-C 3
- Wilson's disease - Identifying predominantly parasympathetic impairment 4
- Morvan syndrome - Characterizing cardiovascular autonomic dysfunction 5
Therapeutic Decision-Making
CAN detection helps tailor therapeutic strategies 1:
- Individualized treatment of orthostatic hypotension, tachycardia, and nocturnal hypertension
- Blood pressure measurement in multiple positions (not just seated) when adjusting antihypertensive therapy
- Avoidance of drugs with adverse autonomic consequences or QT-prolonging potential
- Exercise intensity determination based on perceived exertion rather than heart rate targets
Important Caveats
When NOT to Test
Avoid testing during 1:
- Acute illness, fever, infection, or dehydration
- Hypoglycemia or marked hyperglycemia
- Within 2 hours of short-acting insulin administration
- Within 2 hours of light meals
- Within 24 hours of strenuous exercise
- Within 2 hours of caffeine, alcohol, or smoking
Contraindications
The Valsalva maneuver is contraindicated in proliferative retinopathy or increased risk of retinal hemorrhage 1
Test Interpretation Requirements
- Age-related normal values are mandatory - Age is the most relevant factor affecting heart rate tests 1
- Results should be interpreted cautiously with resting heart rate >100 bpm or in the presence of respiratory/cardiovascular disease, particularly heart failure 1
- Drug washout (especially diuretics, sympatholytics, psychoactive drugs) is ideal; if not feasible, interpret results with caution 1
Diagnostic Criteria Using Ewing Battery
For definitive CAN diagnosis, multiple abnormal tests are required 1:
- Possible/Early CAN: One abnormal cardiovagal test result (requires confirmation over time)
- Definite/Confirmed CAN: At least two abnormal cardiovagal results
- Severe/Advanced CAN: Orthostatic hypotension plus heart rate test abnormalities
The battery consists of heart rate responses to deep breathing, standing, and Valsalva maneuver (parasympathetic indices), plus blood pressure response to standing (sympathetic index) 1. Research indicates the 30:15 ratio (standing test) has the best diagnostic performance with 96% sensitivity and 94% negative predictive value, making it particularly useful for excluding CAN 6.